AKBA
Akebia Therapeutics Inc
Price:  
1.07 
USD
Volume:  
2,136,779.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AKBA EV/EBITDA

14.7%
Upside

As of 2024-06-17, the EV/EBITDA ratio of Akebia Therapeutics Inc (AKBA) is 5.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AKBA's latest enterprise value is 212.46 mil USD. AKBA's TTM EBITDA according to its financial statements is 39.76 mil USD. Dividing these 2 quantities gives us the above AKBA EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 6.4x - 8.2x 7.4x
Forward P/E multiples 3.7x - 7.7x 5.0x
Fair Price 0.75 - 1.62 1.23
Upside -29.9% - 51.0% 14.7%
1.07 USD
Stock Price
1.23 USD
Fair Price

AKBA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-17 5.32
2024-06-14 5.34
2024-06-13 5.61
2024-06-12 5.82
2024-06-11 5.56
2024-06-10 5.45
2024-06-07 5.29
2024-06-06 5.34
2024-06-05 5.50
2024-06-04 5.66
2024-06-03 5.71
2024-05-31 5.61
2024-05-30 5.40
2024-05-29 5.13
2024-05-28 5.34
2024-05-24 5.50
2024-05-23 5.45
2024-05-22 5.50
2024-05-21 5.66
2024-05-20 5.77
2024-05-17 5.77
2024-05-16 5.71
2024-05-15 5.92
2024-05-14 6.19
2024-05-13 6.50
2024-05-10 6.08
2024-05-09 6.71
2024-05-08 7.08
2024-05-07 7.08
2024-05-06 7.56
2024-05-03 6.93
2024-05-02 6.56
2024-05-01 6.24
2024-04-30 6.35
2024-04-29 6.66
2024-04-26 6.77
2024-04-25 6.71
2024-04-24 6.93
2024-04-23 6.93
2024-04-22 6.87
2024-04-19 6.87
2024-04-18 7.03
2024-04-17 7.03
2024-04-16 7.08
2024-04-15 7.03
2024-04-12 7.40
2024-04-11 7.77
2024-04-10 7.93
2024-04-09 7.82
2024-04-08 7.77